NCT06168032
- Conditions
- Antibody, COVID-19 Recurrent, Chemotherapy, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
Clinical trial condition
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
NCT06168032
NCT05258448
NCT06052098
NCT06126406
NCT06010862
NCT05550961
NCT05600569
NCT05502913
NCT04631770
NCT05926336